Home > Result Summaries: Compounds > fosamprenavir > Result Summary for 113156_7

Result Summary for 113156_7

Result Summary

Protocol ID:	113156_7
Clinical Study ID:	WWE113156
Official Title:	Studies using the VA - Studies done under the Oversight Committee for the Evaluation of the metabolic complications of HAART
Phase:	N/A
Study Indications or Diseases:
Generic Name:	fosamprenavir
Trade/Product Name:	Lexiva
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Bozzette SA, Ake CF, Tam HK, et al. Long-Term Survival and Serious Cardiovascular Events in HIV-Infected Patients Treated With Highly Active Antiretroviral Therapy. J Acquir Immune Defic Syndr 2008;47:338–341 Bozzette SA, Ake CF, Tam HK, et al. Cardiovascular and Cerebrovascular Events in Patients Treated for Human Immunodeficiency Virus Infection. N Engl J Med 2003;348:702-710